SuperSonic Imagine凭借其新的肝脏标记物在超声领域进行创新

StephenW

SuperSonic Imagine Innovates in Ultrasound with Its New Liver Markers
GlobeNewswire•October 2, 2019

A suite of three new tools is available on Aixplorer MACH 30 ultrasound platform

AIX-EN-PROVENCE, France, Oct. 01, 2019 (GLOBE NEWSWIRE) -- SuperSonic Imagine (Euronext: SSI, FR0010526814), a company specializing in ultrasound medical imaging, today announced the launch of the new version of its Aixplorer MACH® 30 ultrasound platform, which introduces 3 new ultrasound markers1: Att PLUS, SSp PLUS and Vi PLUS. This new diagnostic approach in ultrasound is made possible thanks to the new generation of UltraFast™ imaging.

“Chronic liver diseases2 are on the rise and represent a major public health issue. Current estimates indicate that 844 million people suffer from liver disease worldwide. As of 2017, we have been developing early diagnostic tools to assist in the clinical management of patients with liver diseases. Thanks to these new tools, we have passed another milestone in the non-invasive assessment of chronic liver disease severity. By combining images with quantitative measurements, our tools will facilitate better patient management throughout the care cycle,” explains Michèle Lesieur, Chief Executive Officer of SuperSonic Imagine.

Aixplorer MACH 30: The expert ultrasound solution for non-invasive exams with quantitative results

SuperSonic Imagine, key innovative player in ultrasound, is now offering a solution to evaluate chronic liver diseases, with three new quantitative markers available on its latest ultrasound platform, Aixplorer MACH 30. Clinicians will now have access to new reliable and reproducible ultrasound markers:

    Att PLUS and SSp PLUS: these two tools allow for the simultaneous quantification of ultrasound attenuation in the liver and intrahepatic speed of sound, reflecting fat content, an essential indicator for the detection and diagnosis of hepatic steatosis;
     
    Vi PLUS: a tool for visualizing and quantifying tissue viscosity. Coupled with real-time elasticity imaging, viscosity assessments provide clinicians with important information for tissue characterization.

These new tools complement the existing range of unique imaging modes developed by SuperSonic Imagine for improved diagnostic performance:
ShearWave™ PLUS allowing for the real-time visualization and measurement of liver elasticity in Kilopascals for the diagnosis of hepatic fibrosis; the hepato-renal index (B-mode Ratio), serving as an aid in the diagnosis of hepatic steatosis. Angio PL.U.S. Doppler mode, which offers unparalleled resolution in the microvasculature detection and contrast imaging, which provides perfusion information, both furnishing complementary data for the characterization of focal liver lesions.
SuperSonic Imagine will introduce its new ultrasound markers for the liver at the 85th edition of the AFEF Scientific Days, booth #13, which will take place in Marseille from 2 to 5 October 2019 and also at the Journées Francophones de Radiologie (JFR), booth #217, level 2, which will be held at the Palais des Congrès in Paris, from 11 to 14 October 2019.

For more information on Aixplorer MACH 30, visit www.Aixplorer-MACH.com or SuperSonic Imagine at www.supersonicimagine.com

StephenW

SuperSonic Imagine凭借其新的肝脏标记物在超声领域进行创新
GlobeNewswire•2019年10月2日

Aixplorer MACH 30超声平台上提供了一套三个新工具

法国艾克斯普罗旺斯地区，2019年10月1日（全球新闻）-专门从事超声医学成像的SuperSonic Imagine（泛欧交易所代码：SSI，FR0010526814）今天宣布推出其新版AixplorerMACH® 30个超声平台，其中引入了3种新的超声标记物1：Att PLUS，SSp PLUS和Vi PLUS。新一代的UltraFast™成像使这种新的超声诊断方法成为可能。

“慢性肝病2呈上升趋势，代表了主要的公共卫生问题。当前的估计表明，全世界有8.44亿人患有肝病。截至2017年，我们一直在开发早期诊断工具，以协助肝病患者的临床管理。借助这些新工具，我们在慢性肝病严重程度的非侵入性评估中又迈出了另一个里程碑。通过将图像与定量测量相结合，我们的工具将有助于在整个护理周期中更好地管理患者。” SuperSonic Imagine首席执行官MichèleLesieur解释说。

Aixplorer MACH 30：专家超声解决方案，用于非侵入性检查，具有定量结果

SuperSonic Imagine是超声领域的关键创新参与者，目前正在提供一种评估慢性肝病的解决方案，其最新的超声平台Aixplorer MACH 30上提供了三种新的定量标记。临床医生现在将可以使用新的可靠且可再现的超声标记：

    Att PLUS和SSp PLUS：这两个工具可同时量化肝脏中超声衰减和肝内声速，反映脂肪含量，这是检测和诊断肝脂肪变性的重要指标；
     
    Vi PLUS：用于可视化和定量组织粘度的工具。结合实时弹性成像，粘度评估为临床医生提供了组织表征的重要信息。

这些新工具补充了SuperSonic Imagine为改善诊断性能而开发的独特成像模式的现有范围：
ShearWave™PLUS可以实时显示和测量千帕斯卡的肝脏弹性，以诊断肝纤维化；肝肾指数（B型比率），有助于诊断肝脂肪变性。 Angio PL.U.S.多普勒模式可在微脉管系统检测和造影成像中提供无与伦比的分辨率，可提供灌注信息，两者均提供了用于表征局灶性肝病灶的补充数据。
SuperSonic Imagine将于2019年10月2日至5日在马赛举行的第85届AFEF科学日第13号展位以及在JournéesFrancophones de Radiologie（JFR）展位上介绍其用于肝脏的新型超声标记物2级＃217号会议将于2019年10月11日至14日在巴黎会议宫举行。

有关Aixplorer MACH 30的更多信息，请访问www.Aixplorer-MACH.com或www.supersonicimagine.com上的SuperSonic Imagine。